Tay-Sachs Essays -- Health Medical Medicine Biology Essays

infantile amaurotic idiocyAbstract infantile amaurotic idiocy is a ailment caused by a mutation to the gene which codes for Hex A. Without Hex A, a cell preservenot degrade GM2 ganglioside into GM3 ganglioside. This results in a build up of gangliosides in lysosomes of neurons. The result is varying degrees of mental deterioration. New DNA-based screening is soon being developed to replace the enzyme-based screening techniques that have been used since 1969. This provide not only speed up the diagnosis, but also yield for earlier detection of Tay-Sachs by using the parents genotypes. Introduction Tay-Sachs disease is one of three autosomal recessive, lysosomal storage disorders, collectively know as the GM2 gangliosidoses. They result from accumulation of GM2 ganglioside in lysosomes, primarily of neurons. The clinical symptoms of Tay-Sachs vary from infantile lethal neurodegenerative disease to less severe crowing onset forms. The latter are often characterized by motor neuro n impairments. The recognition of the high incidence of this disease among Ashkenazi Jews and the acknowledgement of the deficiency of hexosaminidase A as the basic defect were essential findings leading to the establishment of trade carrier screening programs for this disease 2. Recently, research has focused on the DNA-based nosology that are anticipated to play a role in succeeding(a) carrier screening programs 1. GM2 ganglioside hydrolysis The lysosomal hydrolase, beta-hexosaminidase, occurs predominantly in two forms, hexosaminidase A (Hex A) and hexosaminidase B (Hex B). Hex A is comprised of one alpha and one beta fractional monetary unit while Hex B is comprised of two beta subunits 3. While both subunits contain similar active sites, only the alpha subunit can hydrolyze GM2 gan... ... Gravel, R. (1990). The molecular basis of Tay-Sachs disease mutation identification and diagnosis. Clin. Biochem. 23409-415. 2. Navon, R., Proia, R. (1991). Tay-Sachs disease in Moroccan Jews deletion of a phenylalanine in the alpha-subunit of beta--hexosaminidase. Am. J. Hum. Genet. 48412-419. 3. Gray, R.G.F., Green, A., Rabb, L., Broadhead, D.M., Besley, G.T.N. (1990). A case of the B1 variant of GM2-gangliosidosis. J. Inher. Metab. Dis. 13280-282. 4. Meier, E., Schwarzmann, G., Furst, W., Sandhoff, K. (1991). The humanity GM2 activator protein. J. Biological Chem. 2661879-1887. 5. Mahuran, D.J. (1991). The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis. Biochimica et Biophysica Acta. 109687-94. 6. Robbins, S., Ranzi, R., Kumar, V., (Eds). (1984). Pathologic Basis of Disease. Philadelphia, PA Saunders Co. 142-145.